Encefalopatía asociada a Valproato

Valproate can be associated to hyperammonemic encephalopathy, characterized by fluctuating sudden-onset alterations of sensorium, focal symptoms and an increase in the frequency of seizures. We report a 78 year-old female using valproate 1,000 mg/ day for 10 months for the treatment to tonic-clonic...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Young,Pablo, Finn,Bárbara C, Álvarez,Florencia, Bruetman,Julio E, Trimarchi,Hernán
Lenguaje:Spanish / Castilian
Publicado: Sociedad Médica de Santiago 2007
Materias:
Acceso en línea:http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872007001100011
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:scielo:S0034-98872007001100011
record_format dspace
spelling oai:scielo:S0034-988720070011000112008-02-08Encefalopatía asociada a ValproatoYoung,PabloFinn,Bárbara CÁlvarez,FlorenciaBruetman,Julio ETrimarchi,Hernán Carnitine Encephalopathy Hyperammonemia Valproic acid Valproate can be associated to hyperammonemic encephalopathy, characterized by fluctuating sudden-onset alterations of sensorium, focal symptoms and an increase in the frequency of seizures. We report a 78 year-old female using valproate 1,000 mg/ day for 10 months for the treatment to tonic-clonic seizures. She was admitted on three occasions in the last fourth months for self limited clouding of sensorium. Laboratory, imaging and electroencephalografic studies were non-contributory Blood ammonia levels were 123 fig/dl (normal: 15-50 fig/dl). Due to the possibility of a hyperammonemic encephalopathy secondary to valproate, the drug was discontinued and she was treated with lactulose and intravenous L-carnitine, 1 g/day The patient showed a complete recovery within 48 hours. This drug-associated encephalopathy is a reversible but potentially fatal cause, probably underdiagnosed, that requires a high index of suspicioninfo:eu-repo/semantics/openAccessSociedad Médica de SantiagoRevista médica de Chile v.135 n.11 20072007-11-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872007001100011es10.4067/S0034-98872007001100011
institution Scielo Chile
collection Scielo Chile
language Spanish / Castilian
topic Carnitine
Encephalopathy
Hyperammonemia
Valproic acid
spellingShingle Carnitine
Encephalopathy
Hyperammonemia
Valproic acid
Young,Pablo
Finn,Bárbara C
Álvarez,Florencia
Bruetman,Julio E
Trimarchi,Hernán
Encefalopatía asociada a Valproato
description Valproate can be associated to hyperammonemic encephalopathy, characterized by fluctuating sudden-onset alterations of sensorium, focal symptoms and an increase in the frequency of seizures. We report a 78 year-old female using valproate 1,000 mg/ day for 10 months for the treatment to tonic-clonic seizures. She was admitted on three occasions in the last fourth months for self limited clouding of sensorium. Laboratory, imaging and electroencephalografic studies were non-contributory Blood ammonia levels were 123 fig/dl (normal: 15-50 fig/dl). Due to the possibility of a hyperammonemic encephalopathy secondary to valproate, the drug was discontinued and she was treated with lactulose and intravenous L-carnitine, 1 g/day The patient showed a complete recovery within 48 hours. This drug-associated encephalopathy is a reversible but potentially fatal cause, probably underdiagnosed, that requires a high index of suspicion
author Young,Pablo
Finn,Bárbara C
Álvarez,Florencia
Bruetman,Julio E
Trimarchi,Hernán
author_facet Young,Pablo
Finn,Bárbara C
Álvarez,Florencia
Bruetman,Julio E
Trimarchi,Hernán
author_sort Young,Pablo
title Encefalopatía asociada a Valproato
title_short Encefalopatía asociada a Valproato
title_full Encefalopatía asociada a Valproato
title_fullStr Encefalopatía asociada a Valproato
title_full_unstemmed Encefalopatía asociada a Valproato
title_sort encefalopatía asociada a valproato
publisher Sociedad Médica de Santiago
publishDate 2007
url http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872007001100011
work_keys_str_mv AT youngpablo encefalopatiaasociadaavalproato
AT finnbarbarac encefalopatiaasociadaavalproato
AT alvarezflorencia encefalopatiaasociadaavalproato
AT bruetmanjulioe encefalopatiaasociadaavalproato
AT trimarchihernan encefalopatiaasociadaavalproato
_version_ 1718436349612130304